Bober, A.; Piotrowska, A.; Pawlik, K.; Ciapała, K.; Maciuszek, M.; Makuch, W.; Mika, J.
A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model. Int. J. Mol. Sci. 2024, 25, 7410.
https://doi.org/10.3390/ijms25137410
AMA Style
Bober A, Piotrowska A, Pawlik K, Ciapała K, Maciuszek M, Makuch W, Mika J.
A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model. International Journal of Molecular Sciences. 2024; 25(13):7410.
https://doi.org/10.3390/ijms25137410
Chicago/Turabian Style
Bober, Aleksandra, Anna Piotrowska, Katarzyna Pawlik, Katarzyna Ciapała, Magdalena Maciuszek, Wioletta Makuch, and Joanna Mika.
2024. "A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model" International Journal of Molecular Sciences 25, no. 13: 7410.
https://doi.org/10.3390/ijms25137410
APA Style
Bober, A., Piotrowska, A., Pawlik, K., Ciapała, K., Maciuszek, M., Makuch, W., & Mika, J.
(2024). A New Application for Cenicriviroc, a Dual CCR2/CCR5 Antagonist, in the Treatment of Painful Diabetic Neuropathy in a Mouse Model. International Journal of Molecular Sciences, 25(13), 7410.
https://doi.org/10.3390/ijms25137410
